Friday, February 8, 2008


Gardasil, Merck's HPV vaccine, currently has approval for use in the US "on-label" for younger women. This vaccine has the potential to make a difference not only in the landscape of cervical cancer, but also, possibly, other cancers that both men and women might be at risk for--oral, throat, penile and anal cancers all seem to have some correlation with HPV infection.

For this reason, I explored being vaccinated with Gardasil "off-label" with my doctor. This blog will talk about the vaccination process and some of the issues surrounding Gardasil as well as off-label uses of Gardasil, particularly in men.

Now, the issues here are complex, and I'm using this blog to explore them and share them, but you should take everything here with a great deal of skepticism, for reasons that I will be elaborating on in future posts.

Until then, welcome.

No comments: